PORTAGE, Mich. – Today Phadia, the global leader of in vitro diagnostics for allergy, asthma, and autoimmune related diseases, announced that Dennis M. Flannelly has joined the company as Head of U.S. Marketing and Strategy. Prior to joining Phadia, Mr. Flannelly spent his career at Merck where he held a number of progressively-responsible positions, rising […]

AUSTIN, Texas – Luminex Corporation (Nasdaq: LMNX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its xTAG Respiratory Viral Panel FAST (RVP FAST). This front line test has the potential to significantly change the way respiratory viral testing is performed and complements the company’s existing respiratory […]

GnuBIO, Inc. (GnuBIO), www.gnubio.com a pioneer in the Desktop DNA sequencing market, announced today that it has shipped an Early Access system to the Université de Montréal Pharmacogenomics Centre at the Montreal Heart Institute, where the system was used to accurately sequence a blinded cohort of clinical cardiomyopathy samples. The GnuBIO system will allow researchers […]

Albuquerque, N.M. – nanoMR, Inc., today announced that the company has raised $13 million in equity financing. Excel Venture Management led the round, joined by Healthcare Ventures, and existing investors vSpring Capital, The Dow Chemical Company, and Sun Mountain Capital. Dr. Steven Gullans of Excel and Gus Lawlor of Healthcare Ventures will join the board. […]

Marcy l’Etoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, announced that it has acquired ARGENE, a French company specialized in molecular diagnostics. This acquisition is bioMérieux’s tenth in the last five years. With over twenty years of experience in the field of virology diagnostics, ARGENE has 70 employees worldwide. […]

Basel – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany. mtm is a global leader in developing in vitro diagnostics with a focus on early detection and diagnosis of cervical […]

ROCHESTER, Minn. – Mayo Clinic has licensed patent rights from QIAGEN to enable Mayo Medical Laboratories to offer an M. tuberculosis complex speciation test. The test expands Mayo Medical Laboratories’ current offering for tuberculosis testing, which already includes M. tuberculosis complex culture, molecular identification and drug susceptibility testing. In addition, Mayo Medical Laboratories offers polymerase […]

Wetzlar, Germany – Leica Microsystems announces the release of the SlidePath Gateway application for iPad and iPhone, which is the latest addition to the Total Digital Pathology portfolio. SlidePath Gateway is a Digital Pathology viewing application with built-in educational content from leading institutes and pathologists. The free application is available now for download from the […]

London, UK & Novato, California; Proteome Sciences plc (“Proteome”) a global leader in biomarkers will collaborate with Buck Institute for Research on Aging (“Buck”) to develop personalized molecular tests for estrogen receptor alpha (ERa) aimed at improving outcomes in breast cancer. Under the agreement, Proteome will support development of clinical mass spectrometry assays measuring molecular […]